J&J pulls bid for Pfizer consumer biz, GSK, Reckitt remain

Johnson & Johnson has removed itself from the race to buy Pfizer’s consumer health business, leaving GlaxoSmithKline and Reckitt Benckiser among those preparing bids.

Source: Pharma Manufacturing
More...